Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical melatonin for diabetic foot ulcer healing
IRCT20200220046560N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing Melatonin gel with Placebo gel (2 arms). Primary endpoints: wound healing, wound area and 1 more. Started Apr 2021; status: completed.
02
Drugs
melatonin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20200220046560N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200220046560N1.